Scinai Immunotherapeutics Ltd. vs Sussex Research Laboratories Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/scinai-immunotherapeutics/sussex-research

Category	Scinai Immunotherapeutics Ltd.	Sussex Research Laboratories Inc.
Listed site	both	both
Summary	Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.	Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.
Services	CMC Analytical Development Process Development CMC Regulatory Submission Support Technology Transfer Recombinant Protein Manufacturing Biologics Development & Manufacturing	API Synthesis & Manufacturing Small Molecule Development & Manufacturing Process Development CMC Analytical Development Technology Transfer Bioconjugation Services Translational Research Discovery Research Quality Control Testing
Modalities	Biologics (Monoclonal Antibodies)	Small Molecule Biologics (Monoclonal Antibodies) Vaccine Peptide
Indications	Dermatology Immunology Rare Disease	Oncology Infectious Disease Immunology
Locations	Headquarters, Jerusalem, Israel Yavne CDMO Facility, Yavne, Israel	Headquarters, Canada
Certifications	EMA · Identifier: European QP (EMA) audit passed Israeli Ministry of Health · Identifier: Israeli MoH audit passed for Phase 3 clinical trial production	ISO · Identifier: ISO 9001:2015
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.